List of works - Håvard Søiland

A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ

scientific article published on 14 January 2020

Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study

scientific article published on 08 January 2019

Androgen receptor determination in breast cancer: a comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis

scientific article published on 01 July 2008

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

scientific article

Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

scientific article published on 11 March 2008

Benign peritoneal cystic mesothelioma

scientific article

Biologic profiling of lymph node negative breast cancers by means of microRNA expression ⬇️

scientific article published on September 3, 2010

Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients ⬇️

scientific article published on November 29, 2012

Capturing the Experience: Reflections of Women With Breast Cancer Engaged in an Expressive Writing Intervention

scientific article published on 18 September 2015

Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies

scientific article published on 26 October 2020

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

scientific article

Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.

scientific article

Comparison of apolipoprotein D determination methods in breast cancer

scientific article published on 01 March 2008

Corrigendum to "Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study" [The Breast, 44, April 2019, 52-58]

scientific article published on 05 April 2019

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients ⬇️

scientific article published on February 11, 2011

Diet in women with breast cancer compared to healthy controls - What is the difference?

scientific article published on 24 November 2017

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

scientific article published on 29 May 2019

Emerging concepts of apolipoprotein D with possible implications for breast cancer.

scientific article

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls

scientific article published on 2 June 2016

Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors

scientific article

Hypotension and oxygen saturation fall in a woman during sentinel lymph node biopsy ⬇️

scientific article published on May 6, 2011

Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

scientific article

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant! ⬇️

scientific article published on December 28, 2010

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

scientific article published on 08 November 2019

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

scientific article

Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

scientific article published on 30 November 2020

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

scientific article published on 04 December 2019

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients

scientific article published on 08 April 2011

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

scientific article published on 5 October 2016

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

scientific article

Prognostic relevance of androgen receptor detection in operable breast cancer

scientific article

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

scientific article

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients

scientific article published on 28 November 2017

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

scientific article published on September 2013

Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years.

scientific article

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

scientific article

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

scientific article

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer

scientific article published on February 1, 2011

Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial

scientific article published on 12 March 2019

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.

scientific article

List of works by Håvard Søiland

A Quantitative Centrosomal Amplification Score Predicts Local Recurrence of Ductal Carcinoma In Situ

Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study

Androgen receptor determination in breast cancer: a comparison of the dextran-coated charcoal method and quantitative immunohistochemical analysis

Apolipoprotein D expression does not predict breast cancer recurrence among tamoxifen-treated patients

Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer

Benign peritoneal cystic mesothelioma

Biologic profiling of lymph node negative breast cancers by means of microRNA expression ⬇️

Breaking away: High fracture rates may merit a new trial of adjuvant endocrine therapy in Scandinavian breast cancer patients ⬇️

Capturing the Experience: Reflections of Women With Breast Cancer Engaged in an Expressive Writing Intervention

Centrosome amplification: a quantifiable cancer cell trait with prognostic value in solid malignancies

Co-expression of estrogen receptor alpha and Apolipoprotein D in node positive operable breast cancer--possible relevance for survival and effects of adjuvant tamoxifen in postmenopausal patients

Comparing the prognostic value of PTEN and Akt expression with the Mitotic Activity Index in adjuvant chemotherapy-treated node-negative breast cancer patients aged <55 years.

Comparison of apolipoprotein D determination methods in breast cancer

Corrigendum to "Adherence to adjuvant endocrine therapy in postmenopausal breast cancer patients: A 5-year prospective study" [The Breast, 44, April 2019, 52-58]

D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients ⬇️

Diet in women with breast cancer compared to healthy controls - What is the difference?

Drug monitoring of tamoxifen metabolites predicts vaginal dryness and verifies a low discontinuation rate from the Norwegian Prescription Database

Emerging concepts of apolipoprotein D with possible implications for breast cancer.

Fatigue, anxiety and depression overrule the role of oncological treatment in predicting self-reported health complaints in women with breast cancer compared to healthy controls

Functional polymorphisms in UDP-glucuronosyl transferases and recurrence in tamoxifen-treated breast cancer survivors

Hypotension and oxygen saturation fall in a woman during sentinel lymph node biopsy ⬇️

Illness uncertainty in breast cancer patients: validation of the 5-item short form of the Mishel Uncertainty in Illness Scale

In Patients Younger Than Age 55 Years With Lymph Node–Negative Breast Cancer, Proliferation by Mitotic Activity Index Is Prognostically Superior to Adjuvant! ⬇️

Influence of pre-operative oral carbohydrate loading vs. standard fasting on tumor proliferation and clinical outcome in breast cancer patients ─ a randomized trial

LOH at 1p31 (ARHI) and proliferation in lymph node-negative breast cancer.

Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen

Metabolic consequences of perioperative oral carbohydrates in breast cancer patients - an explorative study

Mitotic activity and bone marrow micrometastases have independent prognostic value in node positive breast cancer patients

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age.

Prognostic relevance of androgen receptor detection in operable breast cancer

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients

Serum concentrations of tamoxifen and its metabolites increase with age during steady-state treatment

Success predictors of adjuvant chemotherapy in node-negative breast cancer patients under 55 years.

The Role of MicroRNAs as Predictors of Response to Tamoxifen Treatment in Breast Cancer Patients

The active tamoxifen metabolite endoxifen (4OHNDtam) strongly down-regulates cytokeratin 6 (CK6) in MCF-7 breast cancer cells

The prognostic value of the orphan nuclear receptor DAX-1 (NROB1) in node-negative breast cancer

Thyroidectomy Versus Medical Management for Euthyroid Patients With Hashimoto Disease and Persisting Symptoms: A Randomized Trial

Validating the prognostic value of proliferation measured by Phosphohistone H3 (PPH3) in invasive lymph node-negative breast cancer patients less than 71 years of age.